Suven announces positive topline results from Phase-2 study of Samelisant for EDS in adult…
The study met primary endpoint, with Samelisant demonstrating statistically significant and clinically meaningful reduction in EDS…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.